HYUGA PRIMARY CARE Co.,Ltd. (JP:7133)
:7133
Top Page
HYUGA PRIMARY CARE Co.,Ltd.
(7133)
Select Model
Select Model
Rating:64Neutral
Price Target:
¥1,264.00
▲(9.91% Upside)
Action:DowngradedDate:11/18/25
HYUGA PRIMARY CARE Co.,Ltd. has a strong financial foundation, which is the most significant factor in its overall score. However, the technical analysis indicates bearish momentum, which negatively impacts the stock's attractiveness. The valuation is neutral, providing neither a strong upside nor downside. The absence of earnings call and corporate events data means these factors do not influence the score.
Positive Factors
Strong revenue growth
Sustained ~20.8% revenue growth signals expanding service demand and successful patient/contract scaling in its care facilities. Over 2-6 months this underpins durable top-line momentum, supports pricing power, and provides a base for margin improvement and reinvestment.
Negative Factors
Rising total liabilities
An increase in total liabilities, despite managed leverage, raises structural risk if interest rates or funding costs rise. Over months this can constrain flexibility for M&A or capex, require higher cash generation to service liabilities, and increase refinancing risk.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong revenue growth
Sustained ~20.8% revenue growth signals expanding service demand and successful patient/contract scaling in its care facilities. Over 2-6 months this underpins durable top-line momentum, supports pricing power, and provides a base for margin improvement and reinvestment.
Read all positive factors
HYUGA PRIMARY CARE Co.,Ltd. (7133) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥8.07B
Dividend Yield1.8%
Average Volume (3M)16.77K
Price to Earnings (P/E)18.9
Beta (1Y)0.55
Revenue Growth18.58%
EPS Growth-6.30%
CountryJP
Employees544
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)15.51
Shares Outstanding7,279,000
10 Day Avg. Volume17,690
30 Day Avg. Volume16,766
Financial Highlights & Ratios
PEG Ratio0.23
Price to Book (P/B)4.35
Price to Sales (P/S)1.03
P/FCF Ratio21.24
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)179.3
Revenue Forecast (FY)¥13.20B
HYUGA PRIMARY CARE Co.,Ltd. Business Overview & Revenue Model
Company Description
HYUGA PRIMARY CARE Co.,Ltd. provides home-visit pharmacies, nursing, and care planning services in Japan. The company offers know-how, systems, human resources, and sales for home visiting pharmacy operations to small and medium-sized pharmacy ope...
How the Company Makes Money
HYUGA PRIMARY CARE generates revenue primarily through the provision of medical services to patients, including consultation fees, diagnostic tests, and treatment plans. The company also benefits from partnerships with health insurance providers, ...
HYUGA PRIMARY CARE Co.,Ltd. Financial Statement Overview
Summary
Income Statement
85
Very Positive
Balance Sheet
78
Positive
Cash Flow
82
Very Positive
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 10.33B | 9.98B | 8.29B | 6.66B | 5.78B | 5.09B |
| Gross Profit | 2.41B | 2.41B | 1.88B | 1.56B | 1.24B | 783.83M |
| EBITDA | 1.27B | 1.31B | 854.38M | 627.27M | 568.69M | 258.55M |
| Net Income | 688.09M | 719.03M | 441.03M | 382.88M | 328.45M | 97.14M |
Balance Sheet | ||||||
| Total Assets | 8.02B | 7.05B | 6.35B | 2.92B | 2.54B | 2.02B |
| Cash, Cash Equivalents and Short-Term Investments | 869.34M | 565.93M | 688.01M | 567.69M | 719.56M | 538.29M |
| Total Debt | 3.12B | 2.65B | 2.80B | 251.54M | 330.21M | 447.63M |
| Total Liabilities | 5.72B | 4.68B | 4.71B | 1.44B | 1.46B | 1.41B |
| Stockholders Equity | 2.29B | 2.37B | 1.64B | 1.48B | 1.07B | 609.46M |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 485.51M | 473.20M | 102.59M | 228.92M | 277.22M |
| Operating Cash Flow | 0.00 | 771.32M | 706.64M | 342.25M | 484.60M | 351.82M |
| Investing Cash Flow | 0.00 | -473.98M | -1.13B | -383.39M | -320.25M | -77.59M |
| Financing Cash Flow | 0.00 | -419.43M | 538.78M | -110.73M | 16.93M | 36.64M |
HYUGA PRIMARY CARE Co.,Ltd. Technical Analysis
Neutral
1150.00
Price Trends
1090.46
Positive
1100.57
Negative
1218.36
Negative
Market Momentum
10.42
Negative
54.82
Neutral
42.48
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7133, the sentiment is Neutral. The current price of 1150 is above the 20-day moving average (MA) of 1073.49, above the 50-day MA of 1090.46, and below the 200-day MA of 1218.36, indicating a neutral trend. The MACD of 10.42 indicates Negative momentum. The RSI at 54.82 is Neutral, neither overbought nor oversold. The STOCH value of 42.48 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:7133.
HYUGA PRIMARY CARE Co.,Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥2.83B | 27.02 | ― | 2.56% | -3.06% | -38.56% | |
64 Neutral | ¥8.07B | 18.92 | ― | 1.80% | 18.58% | -6.30% | |
62 Neutral | ¥42.27B | 10.69 | ― | 0.91% | 15.77% | -50.57% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | ¥5.89B | 23.20 | ― | 4.07% | 6.08% | 38.00% | |
45 Neutral | ¥6.41B | -88.53 | ― | 1.41% | 18.03% | -11.68% |
* Healthcare Sector Average
JP:7133
HYUGA PRIMARY CARE Co.,Ltd.
1,108.00
-119.88
-9.76%
JP:2373
Care Twentyone Corporation
436.00
61.14
16.31%
JP:2425
Care Service Co., Ltd.
747.00
-5.39
-0.72%
JP:7061
Japan Hospice Holdings Inc.
761.00
-727.10
-48.86%
JP:7071
Amvis Holdings.Inc.
430.00
-12.07
-2.73%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.